UK watchdog pushes sweeping vet reforms on pricing and transparency

The UK veterinary sector is heading toward one of its biggest regulatory shakeups in decades, with the Competition and Markets Authority proposing a package of reforms aimed at improving price transparency and addressing pet care costs that, in the watchdog’s view, have outpaced what many pet parents can easily navigate. The CMA’s provisional decision, published October 15, 2025, followed its formal market investigation into veterinary services for household pets and laid out remedies that would affect how practices present prices, handle prescriptions, disclose ownership, and communicate with clients. (gov.uk)

The backdrop is a long-running concern that pet parents often struggle to compare practices, understand medicine pricing, or know when they can buy prescribed products elsewhere. The CMA first escalated the issue in March 2024, then opened a full market investigation on May 23, 2024. In its evidence gathering, the authority found that online pricing transparency had improved during the investigation, but remained uneven: in February and March 2024, 84% of 2,552 practice websites it checked had no pricing information, while a later 2025 sample found 59% of first-opinion practices had price information for at least one service. (gov.uk)

The proposed remedies go well beyond a simple call for cheaper care. According to the CMA’s guidance for practices, businesses could be required to publish price lists on their websites and in clinic, provide itemized bills, give written estimates for treatments reasonably expected to cost more than £500, inform pet parents that they can request written prescriptions and that medicines may be cheaper online, cap the fee for written prescriptions, and submit information to the Royal College of Veterinary Surgeons for publication, including ownership details. For multi-site groups, the CMA also wants clearer disclosure that practices are part of a larger corporate network. In its earlier remedies working paper, the CMA said these business-facing requirements could be imposed first through a CMA Order, but should ultimately sit within an independent statutory framework for veterinary businesses. (gov.uk)

That last point matters because it aligns with a longer-standing push from the profession’s regulator. The RCVS has argued that the current legal framework is outdated and that the UK needs a new Veterinary Surgeons Act that would allow regulation of practices as well as individual veterinary surgeons and veterinary nurses. The BVA also welcomed the CMA’s call for vet practice regulation, saying there were “lots of positives” in the provisional decision, including greater transparency on pricing and ownership, while cautioning that overly comprehensive price-list requirements could create confusion and potentially affect animal welfare if implemented poorly. (rcvs.org.uk)

Industry reaction has been supportive in principle, but cautious on execution. The Federation of Independent Veterinary Practices said it backed measures to improve transparency around service costs, medicine costs, and ownership, and was pleased the CMA recognized the need for a new Veterinary Surgeons Act. But it warned that pushing more medicine purchases to online pharmacies could undermine a revenue stream many independent clinics use to support broader service delivery, potentially forcing higher fees elsewhere or even threatening some local practices. The RCVS has voiced a similar concern in earlier submissions, warning that efforts to lower medicines costs should not unintentionally damage practice sustainability or access to care. (fivp.org.uk)

Why it matters: For veterinary professionals, the UK case is becoming a live example of how cost-of-care concerns can evolve into market intervention, operational mandates, and renewed scrutiny of practice business models. Even though this is a UK story, the themes will feel familiar elsewhere: consolidation, client frustration over pricing, pressure around pharmacy margins, and calls for more transparent estimates and billing. If the CMA’s final remedies largely hold, practices may need to rethink client communication workflows, website content, estimate protocols, prescription handling, and governance structures. For regulators and industry groups outside the UK, this investigation may also serve as a template for how competition authorities approach veterinary markets when affordability and transparency become politically salient. (gov.uk)

What to watch: The immediate next step is the CMA’s final decision, which the authority said would be published before the statutory deadline in May 2026 and was expected in February or March 2026; if it proceeds, a formal Order would follow after further consultation, with businesses then getting additional time to comply, typically longer for smaller operators. Also worth watching is whether the UK government turns the CMA’s endorsement of business-level oversight into actual legislative reform of the Veterinary Surgeons Act, which would move the sector from temporary competition remedies toward a more permanent regulatory reset. (gov.uk)